Mount Sinai Hospital, Canada
mountsinai.on.caLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
155
Active
32
Phase 3
18
Total enrollment
44,997
Pipeline matrix
Showing 14 of 14 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Nirmatrelvir/ritonavir | — | — | — | — | — | 1 | |
| Remdesivir | — | — | — | — | — | 1 | |
| Gradual dose reduction of semaglutide | — | — | — | — | — | 1 | |
| Abrupt cessation of semaglutide | — | — | — | — | — | 1 | |
| Normal saline | — | — | — | — | 3 | ||
| Ropivacaine | — | — | — | — | — | 1 | |
| Acetaminophen | — | — | — | — | — | 1 | |
| Ibuprofen 20 mg/mL oral suspension or Ibuprofen lysine 10 mg/mL injection solution | — | — | — | — | — | 1 | |
| Blood or saliva sample collection | — | — | — | — | — | 1 | |
| Start Antibiotics / Continue Antibiotics for treatment of bacteriuria | — | — | — | — | — | 1 | |
| LMWH and LDA | — | — | — | — | — | 1 | |
| Dopamine | — | — | — | — | — | 1 | |
| Norepinephrine | — | — | — | — | — | 1 | |
| Methoxyflurane - Penthrox | — | — | — | — | — | 1 |
Next readouts
- 2025-12-01
- 2026-01
- 2026-06-30
- 2026-07
- 2027-01
- 2027-05
- 2027-09
- 2028-09
- 2030-01
Top conditions
- Type 2 Diabetes8
- Inflammatory Bowel Diseases6
- Crohn Disease6
- Ulcerative Colitis5
- Premature Birth4
- Infertility4
- Influenza4
- Pain4
Frequently asked questions about Mount Sinai Hospital, Canada
- How many clinical trials does Mount Sinai Hospital, Canada have on ClinicalTrials.gov?
- Mount Sinai Hospital, Canada is listed as the lead sponsor on 155 clinical trials in ClinicalTrials.gov, 32 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Mount Sinai Hospital, Canada's trials are in Phase 3?
- 18 of Mount Sinai Hospital, Canada's trials are in Phase 3, spread across 14 active drug programs.
- What therapeutic areas does Mount Sinai Hospital, Canada focus on?
- Mount Sinai Hospital, Canada's most-studied conditions on ClinicalTrials.gov are Type 2 Diabetes, Inflammatory Bowel Diseases, Crohn Disease, Ulcerative Colitis, Premature Birth.
- When are Mount Sinai Hospital, Canada's next clinical trial readouts?
- Mount Sinai Hospital, Canada has 9 upcoming primary-completion readouts tracked here; the soonest is “Methoxyflurane for IUD Insertion and Endometrial Biopsy”, expected around 2025-12-01.